Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Inovalon (INOV) stocks in Canada

Learn how to easily invest in Inovalon stocks.

Inovalon is a health information services business based in the US. Inovalon stocks (INOV.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $32.8 – an increase of 379.79% over the previous week. Inovalon employs 1,836 staff and has a trailing 12-month revenue of around $749.6 million.

How to buy shares in Inovalon

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – INOV – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Inovalon stock price (NASDAQ:INOV)

Use our graph to track the performance of INOV stocks over time.

Inovalon shares at a glance

Information last updated 2022-01-23.
Latest market close$197.00
52-week range$23.18 - $41.06
50-day moving average $40.74
200-day moving average $34.83
Wall St. target price$41.80
PE ratio 122.5672
Dividend yield N/A (0%)
Earnings per share (TTM) $0.34

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Inovalon stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Inovalon price performance over time

Historical closes compared with the close of $197 from 2021-11-26

1 week (2022-01-18) N/A
1 month (2021-12-25) N/A
3 months (2021-10-29) 382.96%
6 months (2021-07-29) 419.93%
1 year (2021-01-29) 707.38%
2 years (2020-01-29) 864.27%
3 years (2019-01-29) 1,335.86%
5 years (2017-01-27) 1,643.36%

Is Inovalon under- or over-valued?

Valuing Inovalon stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Inovalon's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Inovalon's P/E ratio

Inovalon's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 123x. In other words, Inovalon shares trade at around 123x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Inovalon's PEG ratio

Inovalon's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.24. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Inovalon's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Inovalon's EBITDA

Inovalon's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $219.6 million.

The EBITDA is a measure of a Inovalon's overall financial performance and is widely used to measure a its profitability.

Inovalon financials

Revenue TTM $749.6 million
Operating margin TTM 13.8%
Gross profit TTM $499.7 million
Return on assets TTM 3.31%
Return on equity TTM 7.16%
Profit margin 6.92%
Book value $4.91
Market capitalisation $6.4 billion

TTM: trailing 12 months

Inovalon share dividends

We're not expecting Inovalon to pay a dividend over the next 12 months.

Inovalon share price volatility

Over the last 12 months, Inovalon's shares have ranged in value from as little as $23.18 up to $41.06. A popular way to gauge a stock's volatility is its "beta".

INOV.US volatility(beta: 0.53)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Inovalon's is 0.5288. This would suggest that Inovalon's shares are less volatile than average (for this exchange).

Inovalon overview

Inovalon Holdings, Inc. provides cloud-based platforms for data-driven healthcare. It operates Inovalon ONE Platform, an integrated, real-time cloud native platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities. In addition, it offers advisory, implementation, and support services. The company serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. Its platforms include information of data pertaining to approximately one million physicians; 574,000 clinical facilities; and approximately 332 million individuals and 61 billion medical events.

Inovalon in the news

There are no recent company news

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site